Health care startups that raised Series D or later in DACH
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Alentis Therapeutics | Allschwil | Series D | $181.4M | 2024-11-12 |
| CatalYm | Planegg | Series D | $150.0M | 2024-07-16 |
| SkyCell | Zürich | Series D | $59.0M | 2024-06-25 |
| Lunaphore | Lausanne | Series D | $32.7M | 2023-03-23 |
| iThera Medical | Munich | Series D | $13.8M | 2022-12-21 |
| Lophius Biosciences | Regensburg | Series H | $2.4M | 2017-03-18 |
| Affectis Pharmaceuticals | Dortmund | Series D | $4.5M | 2010-03-22 |
7 rows of the CSV in 5 of its 18 columns.
- The 24 health care startups in DACH whose last round is Series D or later have raised $2.5B in total.
- 3 of them closed their most recent round in the last 12 months, $468.4M combined.
- The largest of those rounds is Oviva's $233.7M Series D, dated January 2026.
- The most recent is Nouscom's $134.7M Series D on 19 October 2026.
- Bayern Kapital is an investor in 5 of them, more than any other fund.
- Biotech is the most common other sector, with 15 companies (62%).
- 0% were founded in 2020 or later; the median founding year is 2008.
- The most common team size is 11 to 50 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
6 of 24| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Alentis Therapeutics | Alentis Therapeutics develops novel therapeutics for advanced liver disease and cancer. | Biotech | Allschwil, Switzerland | Series D | $181.4M | 2024-11-12 | Bpifrance, HTGF (High-Tech Gruenderfonds), RA Capital Management +2 | 51 to 100 | 2019 | |
| CatalYm | CatalYm develops immunotherapies to treat cancer. | Biotech | Planegg, Germany | Series D | $150.0M | 2024-07-16 | $260.9M | Bayern Kapital, Forbion Capital Partners, Novartis Venture Fund +1 | 11 to 50 | 2016 |
| SkyCell | SkyCell develops temperature-controlled logistics containers for the pharmaceutical industry. | Health care | Zürich, Switzerland | Series D | $59.0M | 2024-06-25 | M&G Investments, MVM Life Science Partners, Tybourne Capital Management +1 | 101 to 250 | 2013 | |
| Lunaphore | Lunaphore is a life sciences company that creates technologies enabling spatial biology in all laboratories. | Biotech | Lausanne, Switzerland | Series D | $32.7M | 2023-03-23 | Venture Kick, VentureOut, redalpine | 11 to 50 | 2014 | |
| iThera Medical | iThera Medical develops proprietary MSOT imaging technology for preclinical and clinical applications. | Biotech | Munich, Germany | Series D | $13.8M | 2022-12-21 | $42.3M | European Innovation Council, Bayern Kapital, German Federal Ministry of Research, Technology and Space +1 | 11 to 50 | 2010 |
| Phenex Pharmaceuticals | Phenex Pharmaceuticals discovers and develops novel pharmaceutical drugs. | Biotech | Heidelberg, Germany | Series D | $6.5M | 2012-10-31 | KfW, Creathor Ventures, LBBW VC +2 | 11 to 50 | 2002 |
Table 1. Health care startups that raised Series D or later in DACH: the 6 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 24.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Bayern Kapital | Venture capital firm | Landshut, Germany | 5 | 21% | ||
| 2 | KfW | Government investment office | Frankfurt, Germany | 3 | 12% | ||
| 3 | HTGF (High-Tech Gruenderfonds) | Venture capital firm | Bonn, Germany | 2 | 8% | ||
| 4 | Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | 2 | 8% | ||
| 5 | Venture Kick | Startup incubator | Schlieren, Switzerland | 2 | 8% | ||
| 6 | MIG Capital | Venture capital firm | Munich, Germany | 2 | 8% | ||
| 7 | Innosuisse | Government investment office | Berne, Switzerland | 1 | 4% | ||
| 8 | Bpifrance | Government investment office | Maisons-alfort, France | 1 | 4% | ||
| 9 | RA Capital Management | Startup incubator | Boston, United States | 1 | 4% | ||
| 10 | OrbiMed | Private equity firm | New York, United States | 1 | 4% | ||
| 11 | TVM Capital Life Science | Venture capital firm | Munich, Germany | 1 | 4% | ||
| 12 | Signet Healthcare Partners | Venture capital firm | New York, United States | 1 | 4% | ||
| 13 | BayBG Venture Capital | Venture capital firm | Munich, Germany | 1 | 4% | ||
| 14 | Forbion Capital Partners | Private equity firm | Naarden, The Netherlands | 1 | 4% | ||
| 15 | Bioqube Ventures | Venture capital firm | Hasselt, Belgium | 1 | 4% |
Table 2. Health care startups that raised Series D or later in DACH: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 15 | 62% | $721.2M |
| Fintech | 1 | 4% | $174.7M |
| Hardware | 1 | 4% | |
| Software | 1 | 4% | |
| Commerce | 1 | 4% | $112.7M |
| Education | 1 | 4% | $6.5M |
Table 3. Health care startups that raised Series D or later in DACH by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series D+ | 24 | 100% | $33.8M |
Table 4. Health care startups that raised Series D or later in DACH by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| Switzerland | 12 | 50% |
| Germany | 11 | 46% |
| Austria | 1 | 4% |
Table 5. Health care startups that raised Series D or later in DACH by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Munich | 5 | 21% |
| Zürich | 2 | 8% |
| Basel | 1 | 4% |
| Horw | 1 | 4% |
| Innsbruck | 1 | 4% |
| Allschwil | 1 | 4% |
| Planegg | 1 | 4% |
| Lausanne | 1 | 4% |
| Laufen | 1 | 4% |
| Schlieren | 1 | 4% |
| Regensburg | 1 | 4% |
| Mainz | 1 | 4% |
Table 6. Health care startups that raised Series D or later in DACH by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 33% | $134.7M |
| June 2026 | 1 | 33% | $100.0M |
| January 2026 | 1 | 33% | $233.7M |
Table 7. Health care startups that raised Series D or later in DACH: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 3 | 12% | $468.4M |
| 2025 | 1 | 4% | |
| 2024 | 5 | 21% | $590.4M |
| 2023 | 1 | 4% | $32.7M |
| 2022 | 2 | 8% | $47.6M |
| 2020 | 1 | 4% | $5.1M |
Table 8. Health care startups that raised Series D or later in DACH by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2015 to 2019 | 4 | 17% |
| 2010 to 2014 | 7 | 29% |
| Before 2010 | 13 | 54% |
Table 9. Health care startups that raised Series D or later in DACH by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 1 | 4% |
| 11 to 50 | 12 | 50% |
| 51 to 100 | 4 | 17% |
| 101 to 250 | 4 | 17% |
| 251 to 500 | 1 | 4% |
| 501 to 1,000 | 1 | 4% |
| 1,001 to 5,000 | 1 | 4% |
Table 10. Health care startups that raised Series D or later in DACH by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series D or later and its headquarters is in DACH. On 16 November 2026 that is 24 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 6 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 24 rows: 5 have no round amount, 0 no city and 6 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in DACH whose last round is Series D or later are on the list?
- 24, in the file dated 16 November 2026. 3 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 24 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.